Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

A Novel Method for Identifying Transgender and Gender Diverse Patients with Lymphoma: A Single Center Experience

Alison B Alpert, MD MFA, Shea A Nagle, Manuel J Greer, Philip J Meacham, MS, Peter Macdowell, MS, Nicholas Gerbino, Myla Strawderman, MS, Kyle Trenshaw, PhD, Tina Faugh, Carla Casulo

Blood (2019) 134 (Supplement_1): 5825.

https://doi.org/10.1182/blood-2019-126884

Published: 2019

Journal Articles

How I treat primary cutaneous CD30 + lymphoproliferative disorders

Michi M. Shinohara, Andrei Shustov

Blood (2019) 134 (6): 515–524.

https://doi.org/10.1182/blood.2019000785

Published: 2019

Journal Articles

The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas

Rein Willemze, Lorenzo Cerroni, Werner Kempf, Emilio Berti, Fabio Facchetti, Steven H. Swerdlow, Elaine S. Jaffe

Blood (2019) 133 (16): 1703–1714.

https://doi.org/10.1182/blood-2018-11-881268

Published: 2019

Journal Articles

A Successful Experience with Brentuximab Vedotin in Relapsing/Refractory Cutaneous T-Cell Lymphoma: Two Case Reports

Liliya Gorenkova, PhD, Sergey K. Kravchenko, MD PhD, Alla M. Kovrigina, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 5371.

https://doi.org/10.1182/blood-2018-99-115829

Published: 2018

Journal Articles

NPM1-TYK2 Fusion Is an Oncogene and a Novel HSP90-Client Protein

Sudhakiranmayi Kuravi, M.S., Preethi Kunchala, M.S., Siddhartha Ganguly, MD, Sunil Abhyankar, MD, Yogen Saunthararajah, MD, Kojo S. J. Elenitoba-Johnson, MD, Jensen Roy, MD, Joseph McGuirk, DO, Ramesh Balusu, PhD

Blood (2016) 128 (22): 4127.

https://doi.org/10.1182/blood.V128.22.4127.4127

Published: 2016

Journal Articles

Regression of a CD30-Positive Primary Cutaneous T-Cell Lymphoproliferation after Ribavirin Treatment of Chronic Hepatitis E Virus Infection

Julie Bruneau, MD PhD, Vincent Mallet, MD PhD, Julien Zuber, MD PhD, Cecile Alanio, PhD, Stephanie Leclerc, MD, Zakia Choucair, PhD, Kraft Anke, MD PhD, Dominique Roulot, MD, Anne-Marie Roque, MD PhD, Heiner Wedemeyer, MD PhD, Stanislas Pol, MD PhD, Patrick Hillon, MD PhD, Bruno R. Varet, MD PhD, Olivier Hermine, MD PhD

Blood (2016) 128 (22): 4898.

https://doi.org/10.1182/blood.V128.22.4898.4898

Published: 2016

Journal Articles

Evaluation of Health Related Questionnaire Among Mycosis Fungoides and Lymphomatoid Papulosis

Rakhshandra Talpur, MD, Iris Wieser, MD, Casey Wang, Lyons Genevieve, Madeleine Duvic, MD

Blood (2015) 126 (23): 5603.

https://doi.org/10.1182/blood.V126.23.5603.5603

Published: 2015

Journal Articles

Lymphomatoid Papulosis: Assessing Treatment Response and Associated Lymphomas in a Study of 180 Patients

Iris Wieser, MD, Chee Won Oh, MD PhD, Rakhshandra Talpur, MD, Madeleine Duvic, MD

Blood (2015) 126 (23): 1487.

https://doi.org/10.1182/blood.V126.23.1487.1487

Published: 2015

Journal Articles

A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders

Thirunavukkarasu Velusamy, Mark J. Kiel, Anagh A. Sahasrabuddhe, Delphine Rolland, Catherine A. Dixon, Nathanael G. Bailey, Bryan L. Betz, Noah A. Brown, Alexandra C. Hristov, Ryan A. Wilcox, Roberto N. Miranda, L. Jeffrey Medeiros, Yoon K. Jeon, Kedar V. Inamdar, Megan S. Lim, Kojo S. J. Elenitoba-Johnson

Blood (2014) 124 (25): 3768–3771.

https://doi.org/10.1182/blood-2014-07-588434

Published: 2014

Includes: Supplemental data

Journal Articles

Novel Gene Translocations Involving TYK2 in Cutaneous CD30-Positive Lymphoproliferative Disorders

Thirunavukkarasu Velusamy, PhD, Mark J. Kiel, MD PhD, Anagh A Sahasrabuddhe, PhD, Delphine C.M. Rolland, PharmD, PhD, Catherine A Dixon, PhD, Nathanael G. Bailey, MD, Bryan L Betz, PhD, Noah A. Brown, MD, Alexandra C Hristov, MD, Ryan A. Wilcox, MD PhD, Roberto N. Miranda, MD, L. Jeffrey Medeiros, MD, Yoon K Jeon, MD, Megan S Lim, MD PhD, Kojo S.J. Elenitoba-Johnson, MD

Blood (2014) 124 (21): 3032.

https://doi.org/10.1182/blood.V124.21.3032.3032

Published: 2014

Journal Articles

Primary Cutaneous Anaplastic Large Cell Lymphoma: The British Columbia Cancer Agency Experience

Greg Hapgood, BMBS, Laurie H. Sehn, MDMPH, Diego Villa, MDMPH, Richard Klasa, MD, Alina S. Gerrie, MD MPH, Randy D. Gascoyne, MD, Christina Parsons, MD, James Morris, MD, Tom Pickles, MD, Joseph M. Connors, MD, Kerry J. Savage, MDMSc

Blood (2014) 124 (21): 3076.

https://doi.org/10.1182/blood.V124.21.3076.3076

Published: 2014

Journal Articles

High Throughput TCR Sequencing Provides Added Value in the Diagnosis of Cutaneous T-Cell Lymphoma

Ilan Kirsch, MD, David W Williamson, PhD, James Krueger, MD PhD, Jessica Teague, PhD, Christopher Elco, MD PhD, Harlan Robins, PhD, Thomas S. Kupper, MD, Rachael A Clark, MDPhD

Blood (2014) 124 (21): 1683.

https://doi.org/10.1182/blood.V124.21.1683.1683

Published: 2014

Journal Articles

Response Of Rare Variants Of Cutaneous T Cell Lymphoma (CTCL) To Treatment With Bexarotene. A Prospective German DeCOG Trial

Blood (2013) 122 (21): 4379.

https://doi.org/10.1182/blood.V122.21.4379.4379

Published: 2013

Journal Articles

Phase II Trial Of Brentuximab Vedotin For CD30+ Cutaneous T-Cell Lymphomas and Lymphoproliferative Disorders

Madeleine Duvic, MD, Michael Tetzlaff, MD, Audra L Clos, MD, Pamela Gangar, MD, Rakhshandra Talpur, MD

Blood (2013) 122 (21): 367.

https://doi.org/10.1182/blood.V122.21.367.367

Published: 2013

Journal Articles

Results of a Phase II Trial of Brentuximab Vedotin (SGN-35) for CD30+ Cutaneous T-Cell Lymphomas and Lymphoproliferative Disorders

Madeleine Duvic, MD, Michael Tetzlaff, MD, Audra L Clos, MD, Pamela Gangar, MD, Rakhshandra Talpur, MD

Blood (2012) 120 (21): 3688.

https://doi.org/10.1182/blood.V120.21.3688.3688

Published: 2012

Journal Articles

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

Blood (2011) 118 (15): 4024–4035.

https://doi.org/10.1182/blood-2011-05-351346

Published: 2011

Journal Articles

Cutaneous Lymphocyte Antigen and TRAF-1 Are Useful in Differentiating Lymphomatoid Papulosis, Cutaneous ALCL and Systemic ALCL.

Dorna Rezania, MD, Elizabeth Sagatys, MD, L. Frank Glass, MD, Marshall E. Kadin, MD, Hernani Cualing, MD

Blood (2008) 112 (11): 1785.

https://doi.org/10.1182/blood.V112.11.1785.1785

Published: 2008

Journal Articles

Cutaneous Lymphomas: Single Institution Experience in Lima-Peru.

Brady E. Beltrán-Gárate, MD, José Malaga, MD, Karen Portugal, MD, Domingo Morales, MD, Luis Riva, MD, Fernando Hurtado de Mendoza, MD, Jorge Castillo-Aguirre, MD, Pilar Quiñones, MD, Antonio A. Carrasco-Yalan, MD

Blood (2006) 108 (11): 4619.

https://doi.org/10.1182/blood.V108.11.4619.4619

Published: 2006

Journal Articles

Phase II Preliminary Results of SGN-30 (Anti-CD30 mAb) in Patients with CD30+ Lymphoproliferative Disorders.

Madeleine Duvic, MD, Youn Kim, MD, Sunil Reddy, MD, Andres Forero-Torres, MD, Lauren C. Pinter-Brown, MD, Mark U. Rarick, MD, John Zic, MD, Sophie Worobec, MD, Neil Korman, MD, Timothy Kuzel, MD, Kimberly Bohjanen, MD, Karen Flessland, Jeremy Barton, MD, Eric Sievers, MD

Blood (2006) 108 (11): 2733.

https://doi.org/10.1182/blood.V108.11.2733.2733

Published: 2006

Journal Articles

CD30 + Lymphoproliferative Disorder/Lymphomatoid Papulosis - A Regression Caused by Mistletoe Therapy.

Georg Seifert, Christoph Tautz, MD, Karl Seeger, MD, PhD, Guenter Henze, MD, Alfred Laengler, MD

Blood (2005) 106 (11): 4779.

https://doi.org/10.1182/blood.V106.11.4779.4779

Published: 2005

NARROW

A Novel Method for Identifying Transgender and Gender Diverse Patients with Lymphoma: A Single Center Experience

How I treat primary cutaneous CD30 + lymphoproliferative disorders

The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas

A Successful Experience with Brentuximab Vedotin in Relapsing/Refractory Cutaneous T-Cell Lymphoma: Two Case Reports

NPM1-TYK2 Fusion Is an Oncogene and a Novel HSP90-Client Protein

Regression of a CD30-Positive Primary Cutaneous T-Cell Lymphoproliferation after Ribavirin Treatment of Chronic Hepatitis E Virus Infection

Evaluation of Health Related Questionnaire Among Mycosis Fungoides and Lymphomatoid Papulosis

Lymphomatoid Papulosis: Assessing Treatment Response and Associated Lymphomas in a Study of 180 Patients

A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders

Novel Gene Translocations Involving TYK2 in Cutaneous CD30-Positive Lymphoproliferative Disorders

Primary Cutaneous Anaplastic Large Cell Lymphoma: The British Columbia Cancer Agency Experience

High Throughput TCR Sequencing Provides Added Value in the Diagnosis of Cutaneous T-Cell Lymphoma

Response Of Rare Variants Of Cutaneous T Cell Lymphoma (CTCL) To Treatment With Bexarotene. A Prospective German DeCOG Trial

Phase II Trial Of Brentuximab Vedotin For CD30+ Cutaneous T-Cell Lymphomas and Lymphoproliferative Disorders

Results of a Phase II Trial of Brentuximab Vedotin (SGN-35) for CD30+ Cutaneous T-Cell Lymphomas and Lymphoproliferative Disorders

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

Cutaneous Lymphocyte Antigen and TRAF-1 Are Useful in Differentiating Lymphomatoid Papulosis, Cutaneous ALCL and Systemic ALCL.

Cutaneous Lymphomas: Single Institution Experience in Lima-Peru.

Phase II Preliminary Results of SGN-30 (Anti-CD30 mAb) in Patients with CD30+ Lymphoproliferative Disorders.

CD30 + Lymphoproliferative Disorder/Lymphomatoid Papulosis - A Regression Caused by Mistletoe Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only